vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $20.4M, roughly 2.0× Sight Sciences, Inc.). Cambium Networks Corp runs the higher net margin — -17.9% vs -20.4%, a 2.5% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -23.2%). Sight Sciences, Inc. produced more free cash flow last quarter ($-2.0M vs $-10.8M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -27.2%).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
CMBM vs SGHT — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $20.4M |
| Net Profit | $-7.2M | $-4.2M |
| Gross Margin | 36.6% | 87.3% |
| Operating Margin | -28.4% | -18.0% |
| Net Margin | -17.9% | -20.4% |
| Revenue YoY | -23.2% | 6.9% |
| Net Profit YoY | 71.0% | 64.9% |
| EPS (diluted) | $-0.26 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $19.9M | ||
| Q2 25 | — | $19.6M | ||
| Q1 25 | — | $17.5M | ||
| Q4 24 | $40.3M | $19.1M | ||
| Q3 24 | $44.7M | $20.2M | ||
| Q2 24 | $45.2M | $21.4M | ||
| Q1 24 | $47.1M | $19.3M |
| Q4 25 | — | $-4.2M | ||
| Q3 25 | — | $-8.2M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $-14.2M | ||
| Q4 24 | $-7.2M | $-11.8M | ||
| Q3 24 | $-34.5M | $-11.1M | ||
| Q2 24 | $-14.2M | $-12.3M | ||
| Q1 24 | $-18.4M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | 36.6% | 86.8% | ||
| Q3 24 | 43.6% | 83.9% | ||
| Q2 24 | 32.5% | 85.8% | ||
| Q1 24 | 29.8% | 85.5% |
| Q4 25 | — | -18.0% | ||
| Q3 25 | — | -39.7% | ||
| Q2 25 | — | -59.6% | ||
| Q1 25 | — | -79.2% | ||
| Q4 24 | -28.4% | -62.5% | ||
| Q3 24 | -69.6% | -55.7% | ||
| Q2 24 | -27.2% | -59.2% | ||
| Q1 24 | -33.1% | -76.4% |
| Q4 25 | — | -20.4% | ||
| Q3 25 | — | -41.0% | ||
| Q2 25 | — | -61.0% | ||
| Q1 25 | — | -80.8% | ||
| Q4 24 | -17.9% | -62.1% | ||
| Q3 24 | -77.3% | -54.9% | ||
| Q2 24 | -31.5% | -57.7% | ||
| Q1 24 | -39.2% | -84.4% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.28 | ||
| Q4 24 | $-0.26 | $-0.23 | ||
| Q3 24 | $-1.22 | $-0.22 | ||
| Q2 24 | $-0.51 | $-0.25 | ||
| Q1 24 | $-0.66 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $92.0M |
| Total DebtLower is stronger | $67.6M | $42.4M |
| Stockholders' EquityBook value | $-3.2M | $63.9M |
| Total Assets | $173.7M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $101.5M | ||
| Q1 25 | — | $108.8M | ||
| Q4 24 | — | $120.4M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | — | $118.2M | ||
| Q1 24 | — | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | $67.6M | $40.0M | ||
| Q3 24 | $67.6M | $37.1M | ||
| Q2 24 | $68.9M | $35.0M | ||
| Q1 24 | $63.8M | $35.0M |
| Q4 25 | — | $63.9M | ||
| Q3 25 | — | $64.3M | ||
| Q2 25 | — | $70.0M | ||
| Q1 25 | — | $77.6M | ||
| Q4 24 | $-3.2M | $87.5M | ||
| Q3 24 | $1.9M | $95.0M | ||
| Q2 24 | $34.1M | $101.6M | ||
| Q1 24 | $45.0M | $109.2M |
| Q4 25 | — | $115.3M | ||
| Q3 25 | — | $116.3M | ||
| Q2 25 | — | $122.0M | ||
| Q1 25 | — | $129.7M | ||
| Q4 24 | $173.7M | $142.8M | ||
| Q3 24 | $194.3M | $143.6M | ||
| Q2 24 | $221.1M | $149.7M | ||
| Q1 24 | $219.8M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | 36.12× | 0.39× | ||
| Q2 24 | 2.02× | 0.34× | ||
| Q1 24 | 1.42× | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-1.8M |
| Free Cash FlowOCF − Capex | $-10.8M | $-2.0M |
| FCF MarginFCF / Revenue | -26.8% | -9.7% |
| Capex IntensityCapex / Revenue | 1.1% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-8.7M | ||
| Q2 25 | — | $-7.5M | ||
| Q1 25 | — | $-11.6M | ||
| Q4 24 | $-10.4M | $-3.5M | ||
| Q3 24 | $8.9M | $362.0K | ||
| Q2 24 | $2.4M | $-9.5M | ||
| Q1 24 | $-15.9M | $-9.8M |
| Q4 25 | — | $-2.0M | ||
| Q3 25 | — | $-8.9M | ||
| Q2 25 | — | $-7.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-10.8M | $-3.6M | ||
| Q3 24 | $6.8M | $311.0K | ||
| Q2 24 | $87.0K | $-9.5M | ||
| Q1 24 | $-17.4M | $-9.9M |
| Q4 25 | — | -9.7% | ||
| Q3 25 | — | -44.7% | ||
| Q2 25 | — | -39.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | -26.8% | -18.9% | ||
| Q3 24 | 15.2% | 1.5% | ||
| Q2 24 | 0.2% | -44.7% | ||
| Q1 24 | -37.0% | -51.4% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | 1.1% | 0.7% | ||
| Q3 24 | 4.8% | 0.3% | ||
| Q2 24 | 5.1% | 0.4% | ||
| Q1 24 | 3.3% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
